glp-1 agonists diabetes Patients Also Struggle to Access GLP-1 Receptor Agonist Services for

Phase 3 monotherapy available Feature Expected GI burden Cagrilintide + Retatrutide Very high CagriSema (Cag + Sema) High Retatrutide Alone High Feature Dysesthesia risk Cagrilintide + Retatrutide Yes (retatrutide component) CagriSema (Cag + Sema) No Retatrutide Alone Yes Feature Injections per week Cagrilintide + Retatrutide 2 (separate) or 1 (pre-blend) CagriSema (Cag + Sema) 1 or 2 Retatrutide Alone 1 Feature Regulatory status Cagrilintide + Retatrutide Neither approved

This slow buildup helps temper gastrointestinal side effects

The master antioxidant in the body

Today, well take a look at what shin splints really are, how long you can expect to be in recovery, and what you can do to help speed healing